HBW-012-D and HBW-012-E are novel, potent, selective, safe, and bioavailable KRAS G12D inhibitors with superior anti-tumor efficacy in mice
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 15, 2024
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Cancer Research Journal